Click for best price
Blood Pressure Medications Market Size, Share 2024
The global Blood Pressure Medications market was valued at US$ million in 2023 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2023, While China is Forecast to Reach $ Million.
Calcium Channel Blockers Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Blood Pressure Medications include Pfizer, Novartis, AstraZeneca, Bayer, Sanofi, Boehringer Ingelheim, Merck, Lupin Pharmaceuticals and Huahai Pharmaceutical, etc. in 2023, the global top five players have a share approximately % in terms of revenue.
High blood pressure is a common condition that affects the body's arteries. It's also called hypertension. If you have high blood pressure, the force of the blood pushing against the artery walls is consistently too high. The heart has to work harder to pump blood. There are many different high blood pressure medications (antihypertensives) available, each with pros and cons.
This report aims to provide a comprehensive presentation of the global market for Blood Pressure Medications, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Blood Pressure Medications. This report contains market size and forecasts of Blood Pressure Medications in global, including the following market information:
Global Blood Pressure Medications Market Revenue, 2019-2024, 2025-2030, ($ millions)
Global Blood Pressure Medications Market Sales, 2019-2024, 2025-2030, (K Units)
Global top five Blood Pressure Medications companies in 2023 (%)
We surveyed the Blood Pressure Medications manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Blood Pressure Medications Market, by Type, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Blood Pressure Medications Market Segment Percentages, by Type, 2023 (%)
Calcium Channel Blockers
ACE Inhibitors
Angiotensin II Receptor Blockers
Beta Blockers
Compound Drugs
Diuretics
Others
Global Blood Pressure Medications Market, by Application, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Blood Pressure Medications Market Segment Percentages, by Application, 2023 (%)
Hospital
Clinic
Others
Global Blood Pressure Medications Market, By Region and Country, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Blood Pressure Medications Market Segment Percentages, By Region and Country, 2023 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Blood Pressure Medications revenues in global market, 2019-2024 (Estimated), ($ millions)
Key companies Blood Pressure Medications revenues share in global market, 2023 (%)
Key companies Blood Pressure Medications sales in global market, 2019-2024 (Estimated), (K Units)
Key companies Blood Pressure Medications sales share in global market, 2023 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer
Novartis
AstraZeneca
Bayer
Sanofi
Boehringer Ingelheim
Merck
Lupin Pharmaceuticals
Huahai Pharmaceutical
Jiangsu Jibeier Pharmaceutical
Tianjin Pharmaceutical Da Ren Tang Group
Chengdu Easton Biopharmaceuticals
Qingdao Huanghai Pharmaceutical
CR Double-Crane
Shanghai Shyndec Pharmaceutical
CSPC Pharmaceutical Group
Jiangsu Hengrui Medicine
Outline of Major Chapters:
Chapter 1: Introduces the definition of Blood Pressure Medications, market overview.
Chapter 2: Global Blood Pressure Medications market size in revenue and volume.
Chapter 3: Detailed analysis of Blood Pressure Medications manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Blood Pressure Medications in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Blood Pressure Medications capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Blood Pressure Medications Market, Global Outlook and Forecast 2024-2030 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2023 |
| Forecast Year |
2031 |
| Number of Pages |
118 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Blood Pressure Medications Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Blood Pressure Medications Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Blood Pressure Medications Overall Market Size
2.1 Global Blood Pressure Medications Market Size: 2023 VS 2030
2.2 Global Blood Pressure Medications Revenue, Prospects & Forecasts: 2019-2030
2.3 Global Blood Pressure Medications Sales: 2019-2030
3 Company Landscape
3.1 Top Blood Pressure Medications Players in Global Market
3.2 Top Global Blood Pressure Medications Companies Ranked by Revenue
3.3 Global Blood Pressure Medications Revenue by Companies
3.4 Global Blood Pressure Medications Sales by Companies
3.5 Global Blood Pressure Medications Price by Manufacturer (2019-2024)
3.6 Top 3 and Top 5 Blood Pressure Medications Companies in Global Market, by Revenue in 2023
3.7 Global Manufacturers Blood Pressure Medications Product Type
3.8 Tier 1, Tier 2 and Tier 3 Blood Pressure Medications Players in Global Market
3.8.1 List of Global Tier 1 Blood Pressure Medications Companies
3.8.2 List of Global Tier 2 and Tier 3 Blood Pressure Medications Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Blood Pressure Medications Market Size Markets, 2023 & 2030
4.1.2 Calcium Channel Blockers
4.1.3 ACE Inhibitors
4.1.4 Angiotensin II Receptor Blockers
4.1.5 Beta Blockers
4.1.6 Compound Drugs
4.1.7 Diuretics
4.1.8 Others
4.2 By Type - Global Blood Pressure Medications Revenue & Forecasts
4.2.1 By Type - Global Blood Pressure Medications Revenue, 2019-2024
4.2.2 By Type - Global Blood Pressure Medications Revenue, 2025-2030
4.2.3 By Type - Global Blood Pressure Medications Revenue Market Share, 2019-2030
4.3 By Type - Global Blood Pressure Medications Sales & Forecasts
4.3.1 By Type - Global Blood Pressure Medications Sales, 2019-2024
4.3.2 By Type - Global Blood Pressure Medications Sales, 2025-2030
4.3.3 By Type - Global Blood Pressure Medications Sales Market Share, 2019-2030
4.4 By Type - Global Blood Pressure Medications Price (Manufacturers Selling Prices), 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Blood Pressure Medications Market Size, 2023 & 2030
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Others
5.2 By Application - Global Blood Pressure Medications Revenue & Forecasts
5.2.1 By Application - Global Blood Pressure Medications Revenue, 2019-2024
5.2.2 By Application - Global Blood Pressure Medications Revenue, 2025-2030
5.2.3 By Application - Global Blood Pressure Medications Revenue Market Share, 2019-2030
5.3 By Application - Global Blood Pressure Medications Sales & Forecasts
5.3.1 By Application - Global Blood Pressure Medications Sales, 2019-2024
5.3.2 By Application - Global Blood Pressure Medications Sales, 2025-2030
5.3.3 By Application - Global Blood Pressure Medications Sales Market Share, 2019-2030
5.4 By Application - Global Blood Pressure Medications Price (Manufacturers Selling Prices), 2019-2030
6 Sights by Region
6.1 By Region - Global Blood Pressure Medications Market Size, 2023 & 2030
6.2 By Region - Global Blood Pressure Medications Revenue & Forecasts
6.2.1 By Region - Global Blood Pressure Medications Revenue, 2019-2024
6.2.2 By Region - Global Blood Pressure Medications Revenue, 2025-2030
6.2.3 By Region - Global Blood Pressure Medications Revenue Market Share, 2019-2030
6.3 By Region - Global Blood Pressure Medications Sales & Forecasts
6.3.1 By Region - Global Blood Pressure Medications Sales, 2019-2024
6.3.2 By Region - Global Blood Pressure Medications Sales, 2025-2030
6.3.3 By Region - Global Blood Pressure Medications Sales Market Share, 2019-2030
6.4 North America
6.4.1 By Country - North America Blood Pressure Medications Revenue, 2019-2030
6.4.2 By Country - North America Blood Pressure Medications Sales, 2019-2030
6.4.3 US Blood Pressure Medications Market Size, 2019-2030
6.4.4 Canada Blood Pressure Medications Market Size, 2019-2030
6.4.5 Mexico Blood Pressure Medications Market Size, 2019-2030
6.5 Europe
6.5.1 By Country - Europe Blood Pressure Medications Revenue, 2019-2030
6.5.2 By Country - Europe Blood Pressure Medications Sales, 2019-2030
6.5.3 Germany Blood Pressure Medications Market Size, 2019-2030
6.5.4 France Blood Pressure Medications Market Size, 2019-2030
6.5.5 U.K. Blood Pressure Medications Market Size, 2019-2030
6.5.6 Italy Blood Pressure Medications Market Size, 2019-2030
6.5.7 Russia Blood Pressure Medications Market Size, 2019-2030
6.5.8 Nordic Countries Blood Pressure Medications Market Size, 2019-2030
6.5.9 Benelux Blood Pressure Medications Market Size, 2019-2030
6.6 Asia
6.6.1 By Region - Asia Blood Pressure Medications Revenue, 2019-2030
6.6.2 By Region - Asia Blood Pressure Medications Sales, 2019-2030
6.6.3 China Blood Pressure Medications Market Size, 2019-2030
6.6.4 Japan Blood Pressure Medications Market Size, 2019-2030
6.6.5 South Korea Blood Pressure Medications Market Size, 2019-2030
6.6.6 Southeast Asia Blood Pressure Medications Market Size, 2019-2030
6.6.7 India Blood Pressure Medications Market Size, 2019-2030
6.7 South America
6.7.1 By Country - South America Blood Pressure Medications Revenue, 2019-2030
6.7.2 By Country - South America Blood Pressure Medications Sales, 2019-2030
6.7.3 Brazil Blood Pressure Medications Market Size, 2019-2030
6.7.4 Argentina Blood Pressure Medications Market Size, 2019-2030
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Blood Pressure Medications Revenue, 2019-2030
6.8.2 By Country - Middle East & Africa Blood Pressure Medications Sales, 2019-2030
6.8.3 Turkey Blood Pressure Medications Market Size, 2019-2030
6.8.4 Israel Blood Pressure Medications Market Size, 2019-2030
6.8.5 Saudi Arabia Blood Pressure Medications Market Size, 2019-2030
6.8.6 UAE Blood Pressure Medications Market Size, 2019-2030
7 Manufacturers & Brands Profiles
7.1 Pfizer
7.1.1 Pfizer Company Summary
7.1.2 Pfizer Business Overview
7.1.3 Pfizer Blood Pressure Medications Major Product Offerings
7.1.4 Pfizer Blood Pressure Medications Sales and Revenue in Global (2019-2024)
7.1.5 Pfizer Key News & Latest Developments
7.2 Novartis
7.2.1 Novartis Company Summary
7.2.2 Novartis Business Overview
7.2.3 Novartis Blood Pressure Medications Major Product Offerings
7.2.4 Novartis Blood Pressure Medications Sales and Revenue in Global (2019-2024)
7.2.5 Novartis Key News & Latest Developments
7.3 AstraZeneca
7.3.1 AstraZeneca Company Summary
7.3.2 AstraZeneca Business Overview
7.3.3 AstraZeneca Blood Pressure Medications Major Product Offerings
7.3.4 AstraZeneca Blood Pressure Medications Sales and Revenue in Global (2019-2024)
7.3.5 AstraZeneca Key News & Latest Developments
7.4 Bayer
7.4.1 Bayer Company Summary
7.4.2 Bayer Business Overview
7.4.3 Bayer Blood Pressure Medications Major Product Offerings
7.4.4 Bayer Blood Pressure Medications Sales and Revenue in Global (2019-2024)
7.4.5 Bayer Key News & Latest Developments
7.5 Sanofi
7.5.1 Sanofi Company Summary
7.5.2 Sanofi Business Overview
7.5.3 Sanofi Blood Pressure Medications Major Product Offerings
7.5.4 Sanofi Blood Pressure Medications Sales and Revenue in Global (2019-2024)
7.5.5 Sanofi Key News & Latest Developments
7.6 Boehringer Ingelheim
7.6.1 Boehringer Ingelheim Company Summary
7.6.2 Boehringer Ingelheim Business Overview
7.6.3 Boehringer Ingelheim Blood Pressure Medications Major Product Offerings
7.6.4 Boehringer Ingelheim Blood Pressure Medications Sales and Revenue in Global (2019-2024)
7.6.5 Boehringer Ingelheim Key News & Latest Developments
7.7 Merck
7.7.1 Merck Company Summary
7.7.2 Merck Business Overview
7.7.3 Merck Blood Pressure Medications Major Product Offerings
7.7.4 Merck Blood Pressure Medications Sales and Revenue in Global (2019-2024)
7.7.5 Merck Key News & Latest Developments
7.8 Lupin Pharmaceuticals
7.8.1 Lupin Pharmaceuticals Company Summary
7.8.2 Lupin Pharmaceuticals Business Overview
7.8.3 Lupin Pharmaceuticals Blood Pressure Medications Major Product Offerings
7.8.4 Lupin Pharmaceuticals Blood Pressure Medications Sales and Revenue in Global (2019-2024)
7.8.5 Lupin Pharmaceuticals Key News & Latest Developments
7.9 Huahai Pharmaceutical
7.9.1 Huahai Pharmaceutical Company Summary
7.9.2 Huahai Pharmaceutical Business Overview
7.9.3 Huahai Pharmaceutical Blood Pressure Medications Major Product Offerings
7.9.4 Huahai Pharmaceutical Blood Pressure Medications Sales and Revenue in Global (2019-2024)
7.9.5 Huahai Pharmaceutical Key News & Latest Developments
7.10 Jiangsu Jibeier Pharmaceutical
7.10.1 Jiangsu Jibeier Pharmaceutical Company Summary
7.10.2 Jiangsu Jibeier Pharmaceutical Business Overview
7.10.3 Jiangsu Jibeier Pharmaceutical Blood Pressure Medications Major Product Offerings
7.10.4 Jiangsu Jibeier Pharmaceutical Blood Pressure Medications Sales and Revenue in Global (2019-2024)
7.10.5 Jiangsu Jibeier Pharmaceutical Key News & Latest Developments
7.11 Tianjin Pharmaceutical Da Ren Tang Group
7.11.1 Tianjin Pharmaceutical Da Ren Tang Group Company Summary
7.11.2 Tianjin Pharmaceutical Da Ren Tang Group Blood Pressure Medications Business Overview
7.11.3 Tianjin Pharmaceutical Da Ren Tang Group Blood Pressure Medications Major Product Offerings
7.11.4 Tianjin Pharmaceutical Da Ren Tang Group Blood Pressure Medications Sales and Revenue in Global (2019-2024)
7.11.5 Tianjin Pharmaceutical Da Ren Tang Group Key News & Latest Developments
7.12 Chengdu Easton Biopharmaceuticals
7.12.1 Chengdu Easton Biopharmaceuticals Company Summary
7.12.2 Chengdu Easton Biopharmaceuticals Blood Pressure Medications Business Overview
7.12.3 Chengdu Easton Biopharmaceuticals Blood Pressure Medications Major Product Offerings
7.12.4 Chengdu Easton Biopharmaceuticals Blood Pressure Medications Sales and Revenue in Global (2019-2024)
7.12.5 Chengdu Easton Biopharmaceuticals Key News & Latest Developments
7.13 Qingdao Huanghai Pharmaceutical
7.13.1 Qingdao Huanghai Pharmaceutical Company Summary
7.13.2 Qingdao Huanghai Pharmaceutical Blood Pressure Medications Business Overview
7.13.3 Qingdao Huanghai Pharmaceutical Blood Pressure Medications Major Product Offerings
7.13.4 Qingdao Huanghai Pharmaceutical Blood Pressure Medications Sales and Revenue in Global (2019-2024)
7.13.5 Qingdao Huanghai Pharmaceutical Key News & Latest Developments
7.14 CR Double-Crane
7.14.1 CR Double-Crane Company Summary
7.14.2 CR Double-Crane Business Overview
7.14.3 CR Double-Crane Blood Pressure Medications Major Product Offerings
7.14.4 CR Double-Crane Blood Pressure Medications Sales and Revenue in Global (2019-2024)
7.14.5 CR Double-Crane Key News & Latest Developments
7.15 Shanghai Shyndec Pharmaceutical
7.15.1 Shanghai Shyndec Pharmaceutical Company Summary
7.15.2 Shanghai Shyndec Pharmaceutical Business Overview
7.15.3 Shanghai Shyndec Pharmaceutical Blood Pressure Medications Major Product Offerings
7.15.4 Shanghai Shyndec Pharmaceutical Blood Pressure Medications Sales and Revenue in Global (2019-2024)
7.15.5 Shanghai Shyndec Pharmaceutical Key News & Latest Developments
7.16 CSPC Pharmaceutical Group
7.16.1 CSPC Pharmaceutical Group Company Summary
7.16.2 CSPC Pharmaceutical Group Business Overview
7.16.3 CSPC Pharmaceutical Group Blood Pressure Medications Major Product Offerings
7.16.4 CSPC Pharmaceutical Group Blood Pressure Medications Sales and Revenue in Global (2019-2024)
7.16.5 CSPC Pharmaceutical Group Key News & Latest Developments
7.17 Jiangsu Hengrui Medicine
7.17.1 Jiangsu Hengrui Medicine Company Summary
7.17.2 Jiangsu Hengrui Medicine Business Overview
7.17.3 Jiangsu Hengrui Medicine Blood Pressure Medications Major Product Offerings
7.17.4 Jiangsu Hengrui Medicine Blood Pressure Medications Sales and Revenue in Global (2019-2024)
7.17.5 Jiangsu Hengrui Medicine Key News & Latest Developments
8 Global Blood Pressure Medications Production Capacity, Analysis
8.1 Global Blood Pressure Medications Production Capacity, 2019-2030
8.2 Blood Pressure Medications Production Capacity of Key Manufacturers in Global Market
8.3 Global Blood Pressure Medications Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Blood Pressure Medications Supply Chain Analysis
10.1 Blood Pressure Medications Industry Value Chain
10.2 Blood Pressure Medications Upstream Market
10.3 Blood Pressure Medications Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Blood Pressure Medications Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Blood Pressure Medications in Global Market
Table 2. Top Blood Pressure Medications Players in Global Market, Ranking by Revenue (2023)
Table 3. Global Blood Pressure Medications Revenue by Companies, (US$, Mn), 2019-2024
Table 4. Global Blood Pressure Medications Revenue Share by Companies, 2019-2024
Table 5. Global Blood Pressure Medications Sales by Companies, (K Units), 2019-2024
Table 6. Global Blood Pressure Medications Sales Share by Companies, 2019-2024
Table 7. Key Manufacturers Blood Pressure Medications Price (2019-2024) & (US$/Unit)
Table 8. Global Manufacturers Blood Pressure Medications Product Type
Table 9. List of Global Tier 1 Blood Pressure Medications Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Blood Pressure Medications Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global Blood Pressure Medications Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - Global Blood Pressure Medications Revenue (US$, Mn), 2019-2024
Table 13. By Type - Global Blood Pressure Medications Revenue (US$, Mn), 2025-2030
Table 14. By Type - Global Blood Pressure Medications Sales (K Units), 2019-2024
Table 15. By Type - Global Blood Pressure Medications Sales (K Units), 2025-2030
Table 16. By Application ? Global Blood Pressure Medications Revenue, (US$, Mn), 2023 & 2030
Table 17. By Application - Global Blood Pressure Medications Revenue (US$, Mn), 2019-2024
Table 18. By Application - Global Blood Pressure Medications Revenue (US$, Mn), 2025-2030
Table 19. By Application - Global Blood Pressure Medications Sales (K Units), 2019-2024
Table 20. By Application - Global Blood Pressure Medications Sales (K Units), 2025-2030
Table 21. By Region ? Global Blood Pressure Medications Revenue, (US$, Mn), 2023 VS 2030
Table 22. By Region - Global Blood Pressure Medications Revenue (US$, Mn), 2019-2024
Table 23. By Region - Global Blood Pressure Medications Revenue (US$, Mn), 2025-2030
Table 24. By Region - Global Blood Pressure Medications Sales (K Units), 2019-2024
Table 25. By Region - Global Blood Pressure Medications Sales (K Units), 2025-2030
Table 26. By Country - North America Blood Pressure Medications Revenue, (US$, Mn), 2019-2024
Table 27. By Country - North America Blood Pressure Medications Revenue, (US$, Mn), 2025-2030
Table 28. By Country - North America Blood Pressure Medications Sales, (K Units), 2019-2024
Table 29. By Country - North America Blood Pressure Medications Sales, (K Units), 2025-2030
Table 30. By Country - Europe Blood Pressure Medications Revenue, (US$, Mn), 2019-2024
Table 31. By Country - Europe Blood Pressure Medications Revenue, (US$, Mn), 2025-2030
Table 32. By Country - Europe Blood Pressure Medications Sales, (K Units), 2019-2024
Table 33. By Country - Europe Blood Pressure Medications Sales, (K Units), 2025-2030
Table 34. By Region - Asia Blood Pressure Medications Revenue, (US$, Mn), 2019-2024
Table 35. By Region - Asia Blood Pressure Medications Revenue, (US$, Mn), 2025-2030
Table 36. By Region - Asia Blood Pressure Medications Sales, (K Units), 2019-2024
Table 37. By Region - Asia Blood Pressure Medications Sales, (K Units), 2025-2030
Table 38. By Country - South America Blood Pressure Medications Revenue, (US$, Mn), 2019-2024
Table 39. By Country - South America Blood Pressure Medications Revenue, (US$, Mn), 2025-2030
Table 40. By Country - South America Blood Pressure Medications Sales, (K Units), 2019-2024
Table 41. By Country - South America Blood Pressure Medications Sales, (K Units), 2025-2030
Table 42. By Country - Middle East & Africa Blood Pressure Medications Revenue, (US$, Mn), 2019-2024
Table 43. By Country - Middle East & Africa Blood Pressure Medications Revenue, (US$, Mn), 2025-2030
Table 44. By Country - Middle East & Africa Blood Pressure Medications Sales, (K Units), 2019-2024
Table 45. By Country - Middle East & Africa Blood Pressure Medications Sales, (K Units), 2025-2030
Table 46. Pfizer Company Summary
Table 47. Pfizer Blood Pressure Medications Product Offerings
Table 48. Pfizer Blood Pressure Medications Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 49. Pfizer Key News & Latest Developments
Table 50. Novartis Company Summary
Table 51. Novartis Blood Pressure Medications Product Offerings
Table 52. Novartis Blood Pressure Medications Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 53. Novartis Key News & Latest Developments
Table 54. AstraZeneca Company Summary
Table 55. AstraZeneca Blood Pressure Medications Product Offerings
Table 56. AstraZeneca Blood Pressure Medications Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 57. AstraZeneca Key News & Latest Developments
Table 58. Bayer Company Summary
Table 59. Bayer Blood Pressure Medications Product Offerings
Table 60. Bayer Blood Pressure Medications Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 61. Bayer Key News & Latest Developments
Table 62. Sanofi Company Summary
Table 63. Sanofi Blood Pressure Medications Product Offerings
Table 64. Sanofi Blood Pressure Medications Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 65. Sanofi Key News & Latest Developments
Table 66. Boehringer Ingelheim Company Summary
Table 67. Boehringer Ingelheim Blood Pressure Medications Product Offerings
Table 68. Boehringer Ingelheim Blood Pressure Medications Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 69. Boehringer Ingelheim Key News & Latest Developments
Table 70. Merck Company Summary
Table 71. Merck Blood Pressure Medications Product Offerings
Table 72. Merck Blood Pressure Medications Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 73. Merck Key News & Latest Developments
Table 74. Lupin Pharmaceuticals Company Summary
Table 75. Lupin Pharmaceuticals Blood Pressure Medications Product Offerings
Table 76. Lupin Pharmaceuticals Blood Pressure Medications Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 77. Lupin Pharmaceuticals Key News & Latest Developments
Table 78. Huahai Pharmaceutical Company Summary
Table 79. Huahai Pharmaceutical Blood Pressure Medications Product Offerings
Table 80. Huahai Pharmaceutical Blood Pressure Medications Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 81. Huahai Pharmaceutical Key News & Latest Developments
Table 82. Jiangsu Jibeier Pharmaceutical Company Summary
Table 83. Jiangsu Jibeier Pharmaceutical Blood Pressure Medications Product Offerings
Table 84. Jiangsu Jibeier Pharmaceutical Blood Pressure Medications Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 85. Jiangsu Jibeier Pharmaceutical Key News & Latest Developments
Table 86. Tianjin Pharmaceutical Da Ren Tang Group Company Summary
Table 87. Tianjin Pharmaceutical Da Ren Tang Group Blood Pressure Medications Product Offerings
Table 88. Tianjin Pharmaceutical Da Ren Tang Group Blood Pressure Medications Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 89. Tianjin Pharmaceutical Da Ren Tang Group Key News & Latest Developments
Table 90. Chengdu Easton Biopharmaceuticals Company Summary
Table 91. Chengdu Easton Biopharmaceuticals Blood Pressure Medications Product Offerings
Table 92. Chengdu Easton Biopharmaceuticals Blood Pressure Medications Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 93. Chengdu Easton Biopharmaceuticals Key News & Latest Developments
Table 94. Qingdao Huanghai Pharmaceutical Company Summary
Table 95. Qingdao Huanghai Pharmaceutical Blood Pressure Medications Product Offerings
Table 96. Qingdao Huanghai Pharmaceutical Blood Pressure Medications Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 97. Qingdao Huanghai Pharmaceutical Key News & Latest Developments
Table 98. CR Double-Crane Company Summary
Table 99. CR Double-Crane Blood Pressure Medications Product Offerings
Table 100. CR Double-Crane Blood Pressure Medications Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 101. CR Double-Crane Key News & Latest Developments
Table 102. Shanghai Shyndec Pharmaceutical Company Summary
Table 103. Shanghai Shyndec Pharmaceutical Blood Pressure Medications Product Offerings
Table 104. Shanghai Shyndec Pharmaceutical Blood Pressure Medications Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 105. Shanghai Shyndec Pharmaceutical Key News & Latest Developments
Table 106. CSPC Pharmaceutical Group Company Summary
Table 107. CSPC Pharmaceutical Group Blood Pressure Medications Product Offerings
Table 108. CSPC Pharmaceutical Group Blood Pressure Medications Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 109. CSPC Pharmaceutical Group Key News & Latest Developments
Table 110. Jiangsu Hengrui Medicine Company Summary
Table 111. Jiangsu Hengrui Medicine Blood Pressure Medications Product Offerings
Table 112. Jiangsu Hengrui Medicine Blood Pressure Medications Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 113. Jiangsu Hengrui Medicine Key News & Latest Developments
Table 114. Blood Pressure Medications Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2024 (K Units)
Table 115. Global Blood Pressure Medications Capacity Market Share of Key Manufacturers, 2021-2024
Table 116. Global Blood Pressure Medications Production by Region, 2019-2024 (K Units)
Table 117. Global Blood Pressure Medications Production by Region, 2025-2030 (K Units)
Table 118. Blood Pressure Medications Market Opportunities & Trends in Global Market
Table 119. Blood Pressure Medications Market Drivers in Global Market
Table 120. Blood Pressure Medications Market Restraints in Global Market
Table 121. Blood Pressure Medications Raw Materials
Table 122. Blood Pressure Medications Raw Materials Suppliers in Global Market
Table 123. Typical Blood Pressure Medications Downstream
Table 124. Blood Pressure Medications Downstream Clients in Global Market
Table 125. Blood Pressure Medications Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Blood Pressure Medications Segment by Type in 2023
Figure 2. Blood Pressure Medications Segment by Application in 2023
Figure 3. Global Blood Pressure Medications Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global Blood Pressure Medications Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global Blood Pressure Medications Revenue, 2019-2030 (US$, Mn)
Figure 7. Blood Pressure Medications Sales in Global Market: 2019-2030 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Blood Pressure Medications Revenue in 2023
Figure 9. By Type - Global Blood Pressure Medications Revenue, (US$, Mn), 2023 & 2030
Figure 10. By Type - Global Blood Pressure Medications Revenue Market Share, 2019-2030
Figure 11. By Type - Global Blood Pressure Medications Sales Market Share, 2019-2030
Figure 12. By Type - Global Blood Pressure Medications Price (US$/Unit), 2019-2030
Figure 13. By Application - Global Blood Pressure Medications Revenue, (US$, Mn), 2023 & 2030
Figure 14. By Application - Global Blood Pressure Medications Revenue Market Share, 2019-2030
Figure 15. By Application - Global Blood Pressure Medications Sales Market Share, 2019-2030
Figure 16. By Application - Global Blood Pressure Medications Price (US$/Unit), 2019-2030
Figure 17. By Region - Global Blood Pressure Medications Revenue, (US$, Mn), 2023 & 2030
Figure 18. By Region - Global Blood Pressure Medications Revenue Market Share, 2019 VS 2023 VS 2030
Figure 19. By Region - Global Blood Pressure Medications Revenue Market Share, 2019-2030
Figure 20. By Region - Global Blood Pressure Medications Sales Market Share, 2019-2030
Figure 21. By Country - North America Blood Pressure Medications Revenue Market Share, 2019-2030
Figure 22. By Country - North America Blood Pressure Medications Sales Market Share, 2019-2030
Figure 23. US Blood Pressure Medications Revenue, (US$, Mn), 2019-2030
Figure 24. Canada Blood Pressure Medications Revenue, (US$, Mn), 2019-2030
Figure 25. Mexico Blood Pressure Medications Revenue, (US$, Mn), 2019-2030
Figure 26. By Country - Europe Blood Pressure Medications Revenue Market Share, 2019-2030
Figure 27. By Country - Europe Blood Pressure Medications Sales Market Share, 2019-2030
Figure 28. Germany Blood Pressure Medications Revenue, (US$, Mn), 2019-2030
Figure 29. France Blood Pressure Medications Revenue, (US$, Mn), 2019-2030
Figure 30. U.K. Blood Pressure Medications Revenue, (US$, Mn), 2019-2030
Figure 31. Italy Blood Pressure Medications Revenue, (US$, Mn), 2019-2030
Figure 32. Russia Blood Pressure Medications Revenue, (US$, Mn), 2019-2030
Figure 33. Nordic Countries Blood Pressure Medications Revenue, (US$, Mn), 2019-2030
Figure 34. Benelux Blood Pressure Medications Revenue, (US$, Mn), 2019-2030
Figure 35. By Region - Asia Blood Pressure Medications Revenue Market Share, 2019-2030
Figure 36. By Region - Asia Blood Pressure Medications Sales Market Share, 2019-2030
Figure 37. China Blood Pressure Medications Revenue, (US$, Mn), 2019-2030
Figure 38. Japan Blood Pressure Medications Revenue, (US$, Mn), 2019-2030
Figure 39. South Korea Blood Pressure Medications Revenue, (US$, Mn), 2019-2030
Figure 40. Southeast Asia Blood Pressure Medications Revenue, (US$, Mn), 2019-2030
Figure 41. India Blood Pressure Medications Revenue, (US$, Mn), 2019-2030
Figure 42. By Country - South America Blood Pressure Medications Revenue Market Share, 2019-2030
Figure 43. By Country - South America Blood Pressure Medications Sales Market Share, 2019-2030
Figure 44. Brazil Blood Pressure Medications Revenue, (US$, Mn), 2019-2030
Figure 45. Argentina Blood Pressure Medications Revenue, (US$, Mn), 2019-2030
Figure 46. By Country - Middle East & Africa Blood Pressure Medications Revenue Market Share, 2019-2030
Figure 47. By Country - Middle East & Africa Blood Pressure Medications Sales Market Share, 2019-2030
Figure 48. Turkey Blood Pressure Medications Revenue, (US$, Mn), 2019-2030
Figure 49. Israel Blood Pressure Medications Revenue, (US$, Mn), 2019-2030
Figure 50. Saudi Arabia Blood Pressure Medications Revenue, (US$, Mn), 2019-2030
Figure 51. UAE Blood Pressure Medications Revenue, (US$, Mn), 2019-2030
Figure 52. Global Blood Pressure Medications Production Capacity (K Units), 2019-2030
Figure 53. The Percentage of Production Blood Pressure Medications by Region, 2023 VS 2030
Figure 54. Blood Pressure Medications Industry Value Chain
Figure 55. Marketing Channels
